PubMed:25054547 / 0-179 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":142},"obj":"Sentence"}],"text":"Characterization of a novel BCHE \"silent\" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.\nButyrylcholinesterase deficiency is "}

{"project":"LitCoin-entities","denotations":[{"id":"10153","span":{"begin":28,"end":32},"obj":"GeneOrGeneProduct"},{"id":"10154","span":{"begin":66,"end":77},"obj":"SequenceVariant"},{"id":"10155","span":{"begin":117,"end":122},"obj":"DiseaseOrPhenotypicFeature"},{"id":"10156","span":{"begin":128,"end":141},"obj":"ChemicalEntity"},{"id":"10157","span":{"begin":143,"end":175},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"db_id","subj":"10153","obj":"NCBIGene:590"},{"id":"A2","pred":"db_id","subj":"10154","obj":"p|SUB|V|204|D"},{"id":"A3","pred":"db_id","subj":"10155","obj":"MESH:D001049"},{"id":"A4","pred":"db_id","subj":"10156","obj":"MESH:D013390"},{"id":"A5","pred":"db_id","subj":"10157","obj":"MESH:C537417"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Characterization of a novel BCHE \"silent\" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.\nButyrylcholinesterase deficiency is "}

{"project":"LitCoin_Mondo","denotations":[{"id":"T1","span":{"begin":143,"end":175},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0015270"}],"text":"Characterization of a novel BCHE \"silent\" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.\nButyrylcholinesterase deficiency is "}

{"project":"LitCoin-SeqVar","denotations":[{"id":"T1","span":{"begin":66,"end":77},"obj":"SequenceVariant"}],"text":"Characterization of a novel BCHE \"silent\" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.\nButyrylcholinesterase deficiency is "}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T1","span":{"begin":22,"end":27},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":28,"end":32},"obj":"GeneOrGeneProduct"},{"id":"T3","span":{"begin":143,"end":164},"obj":"GeneOrGeneProduct"}],"text":"Characterization of a novel BCHE \"silent\" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.\nButyrylcholinesterase deficiency is "}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T1","span":{"begin":22,"end":27},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":28,"end":32},"obj":"GeneOrGeneProduct"},{"id":"T3","span":{"begin":50,"end":55},"obj":"GeneOrGeneProduct"},{"id":"T4","span":{"begin":56,"end":64},"obj":"GeneOrGeneProduct"},{"id":"T5","span":{"begin":94,"end":102},"obj":"GeneOrGeneProduct"},{"id":"T6","span":{"begin":143,"end":164},"obj":"GeneOrGeneProduct"}],"text":"Characterization of a novel BCHE \"silent\" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.\nButyrylcholinesterase deficiency is "}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T1","span":{"begin":117,"end":122},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":143,"end":175},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"originalLabel","subj":"T1","obj":"D001049"},{"id":"A2","pred":"originalLabel","subj":"T2","obj":"C537417"}],"text":"Characterization of a novel BCHE \"silent\" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.\nButyrylcholinesterase deficiency is "}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T1","span":{"begin":28,"end":32},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":143,"end":164},"obj":"GeneOrGeneProduct"}],"text":"Characterization of a novel BCHE \"silent\" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.\nButyrylcholinesterase deficiency is "}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T1","span":{"begin":143,"end":175},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0015270"}],"text":"Characterization of a novel BCHE \"silent\" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.\nButyrylcholinesterase deficiency is "}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T1","span":{"begin":117,"end":122},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":143,"end":175},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"D001049"},{"id":"A2","pred":"ID:","subj":"T2","obj":"C537417"}],"text":"Characterization of a novel BCHE \"silent\" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.\nButyrylcholinesterase deficiency is "}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T1","span":{"begin":117,"end":122},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":143,"end":175},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"#label","subj":"T1","obj":"D001049"},{"id":"A2","pred":"#label","subj":"T2","obj":"C537417"}],"text":"Characterization of a novel BCHE \"silent\" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.\nButyrylcholinesterase deficiency is "}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T1","span":{"begin":128,"end":141},"obj":"ChemicalEntity"},{"id":"T3","span":{"begin":143,"end":175},"obj":"ChemicalEntity"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"D013390"},{"id":"A2","pred":"ID:","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_45652"},{"id":"A3","pred":"ID:","subj":"T3","obj":"C537417"}],"text":"Characterization of a novel BCHE \"silent\" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.\nButyrylcholinesterase deficiency is "}

{"project":"LitCoin-training-merged","denotations":[{"id":"T3","span":{"begin":143,"end":175},"obj":"ChemicalEntity"},{"id":"T1","span":{"begin":128,"end":141},"obj":"ChemicalEntity"},{"id":"T2","span":{"begin":143,"end":164},"obj":"GeneOrGeneProduct"},{"id":"T44130","span":{"begin":28,"end":32},"obj":"GeneOrGeneProduct"},{"id":"T57186","span":{"begin":143,"end":175},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T88658","span":{"begin":117,"end":122},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T10402","span":{"begin":66,"end":77},"obj":"SequenceVariant"}],"attributes":[{"id":"A3","pred":"ID:","subj":"T3","obj":"C537417"},{"id":"A2","pred":"ID:","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_45652"},{"id":"A1","pred":"ID:","subj":"T1","obj":"D013390"},{"id":"A44419","pred":"#label","subj":"T57186","obj":"C537417"},{"id":"A35754","pred":"#label","subj":"T88658","obj":"D001049"}],"text":"Characterization of a novel BCHE \"silent\" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.\nButyrylcholinesterase deficiency is "}

{"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":142},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":142},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Characterization of a novel BCHE \"silent\" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.\nButyrylcholinesterase deficiency is "}

{"project":"PubCasesHPO","denotations":[{"id":"TI1","span":{"begin":117,"end":122},"obj":"HP:0002104"}],"text":"Characterization of a novel BCHE \"silent\" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.\nButyrylcholinesterase deficiency is "}

{"project":"PubCasesORDO","denotations":[{"id":"AB1","span":{"begin":143,"end":175},"obj":"ORDO:132"}],"namespaces":[{"prefix":"ORDO","uri":"http://www.orpha.net/ORDO/Orphanet_"}],"text":"Characterization of a novel BCHE \"silent\" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.\nButyrylcholinesterase deficiency is "}